Taylor Collinson managed to keep a lot of their capital, selling out just as FTT announced their appointment to negotiate commercial deals after a "successful" trial. Just an idea, but given their vast expereince in negotiating such deals, maybe the FTT board should appoint them again to negotiate commercial deals for the new biotech opportunity the company is currently investigating?